Diplomat Pharmacy sells 7.4 million shares in follow-on offering Cystic fibrosis treatment now available through Diplomat Pharmacy Diplomat to raise $200 million in stock offering Reuters: CVS Health's Brennan believes biosimilars could bring about steeper price cuts Drug Channels lists top 10 specialty pharmacy players Impax completes two acquisitions, reshapes division structure NASP moves closer to Capitol Hill Bloomberg Intelligence reports 2015 will be strong year for biotech Creation of the new GSK, Novartis OTC JV expected for the first week of March Diplomat Pharmacy extends specialty reach with BioRx acquisition First Previous 66 67 68 69 70 Next Last
